7.2. quality life long-term toxicities cure testicular cancer. vast majority patients cured five-year relative survival rates approximately 95% western europe. testicular cancer patients usually 18-40 years age diagnosis life expectancy cure extends several decades . patients informed treatment common long-term toxicities, avoided minimised adherence international guidelines. follow-up, patients screened treated known risk factors hypertension, hyperlipidaemia, testosterone deficiency. adverse health outcomes (ahos) commonly found tc patients received chemotherapy cured surgery alone. further, modifiable risk factors contribute ahos like hypertension noise exposure hearing impairment smoking raynaud phenomenon . therefore, healthy lifestyle promoted follow-up consultations. adverse health outcomes associated unemployment, found clearly increased tc survivors (tcss) compared male normative population . follow-up tc clinician terminated, written cancer survivorship plan addressing late toxic effects, lifestyle recommendations, recurrence risk, cancer-specific follow-up may helpful . *for information regarding long term toxicities quality life issues, please see appendix 3, available online https://uroweb.org/guidelines/testicular-cancer/publications-appendices